Details for New Drug Application (NDA): 050153
✉ Email this page to a colleague
NDA 050153 describes CHLOROMYCETIN, which is a drug marketed by Parke Davis and Parkedale and is included in seven NDAs. Additional details are available on the CHLOROMYCETIN profile page.
The generic ingredient in CHLOROMYCETIN is chloramphenicol; hydrocortisone acetate. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol; hydrocortisone acetate profile page.
The generic ingredient in CHLOROMYCETIN is chloramphenicol; hydrocortisone acetate. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol; hydrocortisone acetate profile page.
Summary for 050153
| Tradename: | CHLOROMYCETIN |
| Applicant: | Parke Davis |
| Ingredient: | chloramphenicol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050153
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 250MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
